Lovastatin combined with insulin effects on fracture healing
in rat models of bilateral ovariectomized type 2 diabetic mellitus

doi:10.3969/j.issn.2095-4344.2440

Abstract

Abstract:

BACKGROUND: Osteoporotic fracture combined with type 2 diabetic mellitus in female patients is often accompanied by dyslipidemia and hyperglycemia. In addition to insulin treatment, statins are often prescribed for combination therapy, but the combined effect of these two drugs on fracture healing has not been reported in such patients.

OBJECTIVE: To investigate the effect of lovastatin combined with insulin on the fracture healing of bilateral ovariectomized rats suffering from type 2 diabetic mellitus.

METHODS: The study was approved by the Ethical Committee of North China University of Science and Technology. Thirty-two female Sprague-Dawley rats were divided into control, diabetic ovariectomized, insulin and combined groups. A model of type 2 diabetes and osteoporosis fracture was established in all rats except for the control group. At 7 days after the type 2 diabetic model was successfully established by injection of streptozotocin, the rats in the insulin and combined groups received the subcutaneous injection of insulin (2-4 U in the morning, and 4-6 U in the evening) until the end of the experiment. The rats in the combined group were given 20 mg/kg lovastatin via gavage daily, and those in the other two groups were not treated. All rats were sacrificed at 3 weeks after fracture. Radiographic, clinical and histomorphometric detections of the callus were performed. The expression levels of bone morphogenetic protein 2, vascular endothelial growth factor and collagen type II were detected. All above results were used to analyze the fracture healing in each group.

RESULTS AND CONCLUSION: (1) The radiographic score, micro-CT index, histologic score and the expression levels of vascular endothelial growth factor and collagen type II in the diabetic ovariectomized group were significantly poorer than those in the control group (P < 0.05). (2) All above indexes in the insulin group were significantly improved compared with the diabetic ovariectomized group (P < 0.05), which promoted the fracture healing of model rats. (3) After combined with lovastatin, although the expression levels of vascular endothelial growth factor and bone morphogenetic protein 2 in the callus were significantly increased (P < 0.05), there was no significant improvement in the radiographic appearance and microstructure of the callus.

Key words: type 2 diabetic mellitus, osteoporosis, estrogen deficiency, fracture, insulin, lovastatin, bone morphogenetic protein 2, vascular endothelial growth factor, collagen type II

CLC Number:

Cao Guolong, Tian Faming, Liu Jiayin. Lovastatin combined with insulin effects on fracture healing in rat models of bilateral ovariectomized type 2 diabetic mellitus[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(5): 673-681.

Figures/Tables 9

References

[1] ENSRUD KE, KATS AM, BOYD CM, et al.Association of Disease Definition, Comorbidity Burden, and Prognosis With Hip Fracture Probability Among Late-Life Women.JAMA Intern Med.2019;17:E1-E9.
[2] DYTFELD J, MICHALAK M.Type 2 diabetes and risk of low-energy fractures in postmenopausal women: meta-analysis of observational studies.Aging Clin Exp Res.2017;29(2):301-309.
[3] MARIN C, LUYTEN FP, VAN DER SCHUEREN B, et al. The Impact of Type 2 Diabetes on Bone Fracture Healing. Front Endocrinol (Lausanne).2018;9(6):1-15.
[4] LA FONTAINE J, CHEN C, HUNT N, et al.Type 2 Diabetes and Metformin Influence on Fracture Healing in an Experimental Rat Model.J Foot Ankle Surg.2016;55(5):955-960.
[5] NAMKUNG-MATTHAI H, APPLEYARD R, JANSEN J, et al. Osteoporosis influences the early period of fracture healing in a rat osteoporotic model.Bone.2001;28(1):80-86.
[6] WANG JW, LI W, XU SW, et al. Osteoporosis influences the middle and late periods of fracture healing in a rat osteoporotic model.Chin J Traumatol.2005;8(2):111-116.
[7] HAK DJ.The biology of fracture healing in osteoporosis and in the presence of anti-osteoporotic drugs.Injury. 2018;49(8):1461-1465.
[8] KLEIN GL.Insulin and bone: Recent developments.World J Diabetes. 2014;5(1):14-16.
[9] KENDRICK J, SHLIPAK MG, TARGHER G, et al.Effect of lovastatin on primary prevention of cardiovascular events in mild CKD and kidney function loss: A post hoc analysis of the Air Force/Texas Coronary Atherosclerosis Prevention Study.Am J Kidney Dis. 2010;55(1):42-49.
[10] GIANNOTTI S, BOTTAI V, DELL’OSSO G, et al.Current medical strategies concerning fracture healing. Clin Cases Miner Bone Metab.2013;10(2):116-120.
[11] IBRAHIM N', KHAMIS MF, MOD YUNOH MF, et al.Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation.PLoS One.2014;9(12):1-18.
[12] SRINIVASAN K, VISWANAD B, ASRAT L, et al.Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.Pharmacol Res.2005;52(4):313–320.
[13] ACAR B, KÖSE Ö, AYTAÇ G, et al.Diabetes mellitus accelerates fatty degeneration of the supraspinatus muscle after tendon tear: An experimental study in rats.Eklem Hastalik Cerrahisi. 2018; 29(3):176-183.
[14] HOLSTEIN JH, MENGER MD, CULEMANN U, et al.Development of a locking femur nail for mice. J Biomech. 2007;40(1):215-219.
[15] WONG E, SANGADALA S, BODEN SD, et al.A novel low-molecular- weight compound enhances ectopic bone formation and fracture repair.J Bone Joint Surg Am.2013;95(5):454-461.
[16] SUZUKI K, MIYAKOSHI N, TSUCHIDA T, et al. Effects of combined treatment of insulin and human parathyroid hormone (1-34) on cancellousbone mass and structure in streptozotocin- induced diabetic rats.Bone.2003;33(1):108-114.
[17] SHAHREZAEE M, ORYAN A, BASTAMI F, et al.Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats. Endocrine.2018;60(1):138-150.
[18] CHUENG KM, KALUARACHI K, ANDREW G, et al. An externally fixed femoral fracture model for mice. J Orthop Res. 2003;21(4):685-690.
[19] AKMAN S, GÖGÜS A, SENER N, et al.Effect of diclofenac sodium on union of tibial fractures in rats. Adv Ther.2002;19(3):119-125.
[20] WANG L, HSIAO EC, LIEU S, et al. Loss of Gi G-Protein-Coupled Receptor Signaling in Osteoblasts Accelerates Bone Fracture Healing.J Bone Miner Res.2015;30(10):1896-1904.
[21] NYMAN JS, MUNOZ S, JADHAV S, et al.Quantitative measures of femoral fracture repair in rats derived by micro-computed tomography.J Biomech.2009;42(7):891-897.
[22] HUO MH, TROIANO NW, PELKER RR, et al.The influence of ibuprofen on fracture repair: Biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res. 1991;9(3): 383-390.
[23] LI B, WANG Y, LIU Y, et al. Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model. Endocrine.2013;43(1):136-146.
[24] JIAO H, XIAO E, GRAVES DT. Diabetes and Its Effect on Bone and Fracture Healing. Curr Osteoporos Rep.2015;13(5):327-335.
[25] HERNANDEZ RK, DO TP, CRITCHLOW CW, et al. Patient‐related risk factors for fracture‐healing complications in the United Kingdom General Practice Research Database.Acta Orthop. 2012;83(6):653-660.
[26] CUNHA JS, FERREIRA VM, MAQUIGUSSA E, et al.Effects of high glucose and high insulin concentrations on osteoblast function in vitro.Cell Tissue Res.2014;358(1):249-256.
[27] BOTOLIN S, MCCABE LR.Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways.J Cell Biochem.2006;99(2):411-424.
[28] SUN M, YANG J, WANG J, et al. TNF-α is upregulated in T2DM patients with fracture and promotes the apoptosis of osteoblast cells in vitro in the presence of high glucose.Cytokine. 2016;80: 35-42.
[29] KO KI, COIMBRA LS, TIAN C, et al.Diabetes reduces mesenchymal stem cells in fracture healing through a TNFalpha-mediated mechanism. Diabetologia.2015;58(3):633-642.
[30] KAYAL RA, TSATSAS D, BAUER MA, et al. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. JBoneMiner Res.2007;22(4):560-568.
[31] HAN D, ZHANG P, JIANG B.Local administration of IKK small molecule inhibitor may enhance fracture healing in osteoporosis patient.Int J Clin Exp Med.2015;8(1):1411-1415.
[32] JAHNG JS, KIM HW.Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics.2000;23(10):1089-1094.
[33] BEIL FT, BARVENCIK F, GEBAUER M, et al.Effects of estrogen on fracture healing in mice.J Trauma.2010;69(5):1259-1265.
[34] ISLAM AA, RASUBALA L, YOSHIKAWA H, et al. Healing of fractures in osteoporotic rat mandible shown by the expression of bone morphogenetic protein-2 and tumour necrosis factor-α.Br J Oral Maxillofac Surg.2005;43(5):383-391.
[35] SAITO M, MARUMO K.Collagen cross-links as a determinant of bone quality:A possible explanation for bone fragility in aging, osteoporosis,and diabetes mellitus.Osteoporos Int.2010;21(2): 195-214.
[36] WEINBERG E, MAYMON T, WEINREB M. Ages induce caspase- mediated apoptosis of rat bmscs via tnfalpha production and oxidative stress.J Mol Endocrinol.2014;52(1):67-76.
[37] PENTTI K, TUPPURAINEN MT, HONKANEN R, et al. Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study. Eur J Endocrinol. 2009;160(6):979-983.
[38] BRYZGALOVA G, GAO H, AHREN B, et al. Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice:insulin sensitivity in the liver. Diabetologia.2006;49(3):588-597.
[39] LUNDHOLM L, BRYZGALOVA G, GAO H, et al.The estrogen receptor alpha-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms.J Endocrinol.2008;199(2):275-286.
[40] BRAGDON B, LYBRAND K, GERSTENFELD L.Overview of Biological Mechanisms and Applications of Three Murine Models of Bone Repair:Closed Fracture with Intramedullary Fixation, Distraction Osteogenesis, and Marrow Ablation by Reaming.Curr Protoc Mouse Biol.2015;5(1):21-34.
[41] PICKE AK, GORDALIZA ALAGUERO I, CAMPBELL GM. Campbell. Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy.Bone. 2016; 82:108-115.
[42] PARK AG, PAGLIA DN, AL-ZUBE L, et al.Local Insulin Therapy Affects Fracture Healing in a Rat Model.J Orthop Res.2013; 31(5):776-782.
[43] WANG DW, DU SL, XU MT, et al.Effects of insulin therapy on fracture healing and expression of VEGF in diabetic rats.J Appl Biomed.2013; 11:33-40.
[44] HU KAI, OLSEN BR.Vascular Endothelial Growth Factor Control Mechanisms in Skeletal Growth and Repair.Dev Dyn.2017;246(4): 227-234.
[45] ZHANG R, LIANG Y, WEI S.The expressions of NGF and VEGF in the fracture tissues are closely associated with accelerated clavicle fracture healing in patients with traumatic brain injury. Ther Clin Risk Manag.2018;14:2315-2322.
[46] DING Q, SUN P, ZHOU H, et al.Lack of endogenous parathyroid hormone delays fracture healing by inhibiting vascular endothelial growth factor-mediated angiogenesis.Int J Mol Med.2018;42(1): 171-181.
[47] MAYR-WOHLFART U, WALTENBERGER J, HAUSSER H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts.Bone.2002;30(3):472-477.
[48] HU K, OLSEN BR.Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair.J Clin Invest. 2016;126(2):509-526.
[49] LIAN C, WANG X, QIU X, et al. Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin β1−SMAD1 interaction.Bone Res.2019; 7(8):1-15.
[50] TIRUVANNAMALAI ANNAMALAI R, MERTZ DR, DALEY EL. Collagen Type II enhances chondrogenic differentiation in agarose-based modular microtissues.Cytotherapy. 2016;18(2): 263-277.
[51] BIBBINS-DOMINGO K, GROSSMAN DC, CURRY SJ, et al.Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement. JAMA.2016;316(19):1997-2007.
[52] CHIN KY, ABDUL-MAJEED S, MOHAMED N, et al.The Effects of Tocotrienol and Lovastatin Co-Supplementation on Bone Dynamic Histomorphometry and Bone Morphogenetic Protein-2 Expression in Rats with Estrogen Deficiency. Nutrients.2017;9(2): 1-12.
[53] JADHAV SB, NARAYANA MURTHY PS, SINGH MM, et al. Distribution of lovastatin to bone and its effect on bone turnover in rats.J Pharm Pharmacol.2006;58(11):1451-1458.
[54] MOSHIRI A, SHARIFI AM, ORYAN A.Role of Simvastatin on fracture healing and osteoporosis: a systematic review on in vivo investigations. Clin Exp Pharmacol Physiol. 2016;43(7):659-684.
[55] MAEDA T, KAWANE T, HORIUCHI N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation.Endocrinology.2003;144(2): 681-692.
[56] BRAMONO DS, MURALI S, RAI B, et al.Bone marrow-derived heparan sulfate potentiates the osteogenic activity of bone morphogenetic protein-2 (BMP-2).Bone.2012;50(4):954-964.
[57] LI J, WANG JJ, CHEN D, et al. Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.Exp Eye Res. 2009; 89(1): 71-78.
[58] AWAD E, OTHMAN EM, STOPPER H.Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro.Molecules.2017;22(12):1-12.
[59] TANG QO, TRAN GT, GAMIE Z, et al.Statins: under investigation for increasing bone mineral density and augmenting fracture healing. Expert Opin Investig Drugs.2008;17(10):1435-1463.